tiprankstipranks
Trending News
More News >
Cranswick plc (GB:CWK)
:CWK
UK Market
Advertisement

Cranswick (CWK) AI Stock Analysis

Compare
40 Followers

Top Page

GB:CWK

Cranswick

(LSE:CWK)

Select Model
Select Model
Select Model
Outperform 71 (OpenAI - 4o)
Rating:71Outperform
Price Target:
5,613.00p
▲(10.06% Upside)
Cranswick's strong financial performance is the most significant factor driving its overall score, supported by solid revenue growth and profitability. However, technical indicators suggest bearish momentum, which tempers the overall outlook. The valuation is moderate, providing a balanced view of potential risks and rewards.
Positive Factors
Revenue Growth
Consistent revenue growth indicates expanding market reach and product adoption, supporting long-term business sustainability and competitive positioning.
Cash Generation
Strong cash generation enhances financial flexibility, enabling strategic investments and debt management, which are crucial for sustaining growth and stability.
Profitability
Sustained profitability through effective cost management supports long-term financial health and the ability to reinvest in business operations.
Negative Factors
Leverage Position
Moderate leverage requires prudent debt management to avoid financial strain, which could impact the company's ability to invest in growth opportunities.
Revenue Growth Volatility
Volatility in revenue growth can indicate market challenges or operational inefficiencies, potentially affecting long-term growth projections and stability.
Capital Expenditure Fluctuations
Fluctuating capital expenditures can impact free cash flow stability, potentially limiting the company's ability to fund new projects or manage debt effectively.

Cranswick (CWK) vs. iShares MSCI United Kingdom ETF (EWC)

Cranswick Business Overview & Revenue Model

Company DescriptionCranswick plc manufactures and supplies food products to grocery retailers, food service sector, and other food producers in the United Kingdom, Continental Europe, and internationally. The company offers fresh pork, gourmet bacon and gammon, fresh and coated chicken, ready to eat chicken, charcuterie, houmous and dips, and olives and antipasti, gourmet sausages, cooked meats, gourmet pastries, and ingredients, as well as cheeses and pasta. It also offers snacks and sharing boxes under the Bodega brand; olives, olive oil, and pulses under the Cypressa brand; Mediterranean foods under the Ramona's Kitchen brand name; and pet food and supplies under the Vitalin and Alpha Feeds, as well as operates export business. The company was incorporated in 1972 and is based in Hessle, the United Kingdom.
How the Company Makes MoneyCranswick generates revenue primarily through the sale of its food products across various sectors. The company has a diverse revenue model that includes direct sales to major grocery retailers, wholesale distribution to foodservice providers, and exports to international markets. Key revenue streams come from fresh pork, cooked meats, and other processed products, with a significant portion of its sales attributed to long-term contracts and partnerships with leading supermarket chains. Additionally, Cranswick invests in product innovation and quality assurance, enabling it to maintain premium pricing and enhance customer loyalty, which further contributes to its overall earnings.

Cranswick Financial Statement Overview

Summary
Cranswick presents a solid financial profile with strong revenue growth and profitability metrics. The company's balance sheet supports ongoing operations with manageable leverage, while cash flow generation remains strong. Continuous improvements in income margins and prudent capital management will further strengthen its financial standing.
Income Statement
84
Very Positive
Cranswick demonstrates strong growth in revenue, with a consistent upward trend over the years. The company has managed to maintain a healthy gross profit margin and an improving net profit margin, indicating effective cost management and profitability. EBIT and EBITDA margins are solid, reflecting efficient operations. However, the slight volatility in revenue growth rate needs monitoring.
Balance Sheet
78
Positive
The balance sheet shows a stable financial position with increasing stockholders' equity, indicating retained earnings and strong equity backing. The debt-to-equity ratio remains manageable, reflecting prudent financial leverage. Return on equity is satisfactory, indicating effective utilization of equity. However, the equity ratio suggests a moderately leveraged position, which necessitates careful debt management to maintain stability.
Cash Flow
82
Very Positive
Cranswick's cash flow statements highlight robust operating cash flow, consistently exceeding net income, which reflects strong cash generation capabilities. Free cash flow growth is positive, though some fluctuations in capital expenditures are noted. The operating cash flow to net income ratio is healthy, indicating efficient conversion of earnings to cash. Continued focus on optimizing capital expenditures would enhance free cash flow stability.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.72B2.72B2.60B2.32B2.01B1.90B
Gross Profit419.90M408.80M376.90M295.70M276.80M265.70M
EBITDA275.70M280.70M253.60M220.00M199.00M185.50M
Net Income134.30M134.30M113.10M111.40M103.50M92.50M
Balance Sheet
Total Assets1.53B1.53B1.38B1.26B1.14B1.04B
Cash, Cash Equivalents and Short-Term Investments5.90M5.90M27.00M20.40M200.00K39.90M
Total Debt178.30M178.30M127.40M121.70M106.20M131.40M
Total Liabilities543.30M543.30M472.50M421.50M373.60M355.00M
Stockholders Equity987.90M987.90M911.50M842.90M768.90M686.10M
Cash Flow
Free Cash Flow78.70M78.70M127.90M64.10M64.70M109.00M
Operating Cash Flow216.30M216.30M228.40M149.20M158.40M180.90M
Investing Cash Flow-160.40M-160.40M-123.30M-83.80M-130.90M-81.80M
Financing Cash Flow-77.00M-77.00M-93.40M-45.30M-66.30M-81.60M

Cranswick Technical Analysis

Technical Analysis Sentiment
Negative
Last Price5100.00
Price Trends
50DMA
5201.93
Negative
100DMA
5198.41
Negative
200DMA
5024.31
Positive
Market Momentum
MACD
-29.52
Negative
RSI
45.10
Neutral
STOCH
48.55
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:CWK, the sentiment is Negative. The current price of 5100 is below the 20-day moving average (MA) of 5150.50, below the 50-day MA of 5201.93, and above the 200-day MA of 5024.31, indicating a neutral trend. The MACD of -29.52 indicates Negative momentum. The RSI at 45.10 is Neutral, neither overbought nor oversold. The STOCH value of 48.55 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:CWK.

Cranswick Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
£2.73B20.2714.14%1.98%4.77%18.94%
69
Neutral
1.61B12.968.66%1.50%1.01%11.12%
67
Neutral
2.24B35.508.99%3.91%5.40%-67.46%
66
Neutral
603.17M15.3212.82%5.13%8.58%-15.81%
64
Neutral
1.05B19.7410.28%0.83%0.49%14.18%
61
Neutral
1.27B33.319.04%2.71%0.59%-41.66%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:CWK
Cranswick
5,100.00
500.96
10.89%
GB:HFG
Hilton Food
672.00
-193.60
-22.37%
GB:PFD
Premier Foods
187.00
8.34
4.67%
GB:TATE
Tate & Lyle
507.00
-136.46
-21.21%
GB:GNC
Greencore
242.50
61.85
34.24%
GB:BAKK
Bakkavor Group plc
220.00
66.30
43.14%

Cranswick Corporate Events

Dividends
Cranswick Announces Dividend Reinvestment by Director’s Associate
Positive
Sep 15, 2025

Cranswick plc announced a transaction involving the reinvestment of dividends into shares by Sophia Bottomley, who is closely associated with John Mark Bottomley, a director at Cranswick. The transaction, involving 42 ordinary shares at a price of 5205.6p each, took place on the London Stock Exchange on September 12, 2025. This move reflects the company’s ongoing commitment to shareholder value and may indicate confidence in Cranswick’s market position and future prospects.

The most recent analyst rating on (GB:CWK) stock is a Buy with a £5802.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.

Business Operations and StrategyDividends
Cranswick Announces Director-Linked Share Reinvestment
Positive
Sep 15, 2025

Cranswick plc announced a transaction involving Saskia Bottomley, who is closely associated with John Mark Bottomley, a Director at the company. The transaction involved the reinvestment of dividends into ordinary shares, with a total of 57 shares purchased at a price of 5205.6 pence each on the London Stock Exchange. This transaction reflects a strategic reinvestment approach by individuals closely linked to the company’s leadership, potentially indicating confidence in Cranswick’s market position and future prospects.

The most recent analyst rating on (GB:CWK) stock is a Buy with a £5802.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.

Regulatory Filings and Compliance
Cranswick Announces Total Voting Rights Update
Neutral
Sep 11, 2025

Cranswick plc has announced that as of 10 September 2025, the company has a total of 54,270,567 ordinary shares in issue, each carrying one vote. This information is crucial for shareholders to determine their notification requirements regarding their interest in the company’s share capital under the Financial Conduct Authority’s Disclosure and Transparency Rules.

The most recent analyst rating on (GB:CWK) stock is a Hold with a £5530.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.

Business Operations and Strategy
Cranswick Director Acquires Shares Under Incentive Plan
Positive
Aug 26, 2025

Cranswick plc announced that Director Christopher Aldersley acquired ordinary shares under the company’s 2024 Buy As You Earn Share Incentive Plan. This transaction, part of a regular monthly purchase program, reflects ongoing confidence in the company’s strategic direction and its commitment to aligning management interests with those of shareholders.

The most recent analyst rating on (GB:CWK) stock is a Buy with a £62.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.

Regulatory Filings and Compliance
Cranswick Announces Total Voting Rights Update
Neutral
Aug 4, 2025

Cranswick plc has announced that as of August 1, 2025, the total number of ordinary shares in its capital is 54,264,605, with each share granting one voting right. This figure is crucial for shareholders to determine their notification requirements under the Financial Conduct Authority’s Disclosure and Transparency Rules.

The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.

Business Operations and StrategyShareholder Meetings
Cranswick Passes All AGM Resolutions, Continues Shareholder Engagement on Remuneration
Neutral
Jul 28, 2025

Cranswick plc announced that all resolutions proposed at its 2025 Annual General Meeting were successfully passed, with most receiving significant majorities. However, the resolution concerning the Directors’ Remuneration Report received less than 80% approval, prompting the Board to continue engaging with shareholders to address their concerns. This engagement reflects Cranswick’s commitment to aligning with shareholder expectations and adhering to the UK Corporate Governance Code.

The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.

Business Operations and StrategyFinancial DisclosuresM&A TransactionsPrivate Placements and Financing
Cranswick Reports Strong Q1 Growth and Strategic Investments
Positive
Jul 28, 2025

Cranswick reported strong trading in the first quarter of the financial year, with a 9.7% increase in revenue compared to the previous year, driven by new business wins and strong demand for premium products. The acquisition of Blakemans contributed positively, and export revenue was bolstered by the reinstatement of the Norfolk pork site’s China export license. The company is accelerating capital expenditure to enhance capacity and efficiency, with significant investment in the Lincoln Pet Products site. Cranswick also refinanced its banking facility, securing a £360 million revolving credit facility to support future growth.

The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.

Regulatory Filings and Compliance
Cranswick plc Discloses Managerial Share Transaction
Neutral
Jul 24, 2025

Cranswick plc announced a transaction involving the sale of 4,000 ordinary shares by Christie Brisby, the spouse of Director James Robert Brisby, on the London Stock Exchange. This transaction, disclosed as part of regulatory requirements, may impact the company’s stock dynamics and reflects internal managerial activities, potentially influencing stakeholder perceptions.

The most recent analyst rating on (GB:CWK) stock is a Hold with a £4900.00 price target. To see the full list of analyst forecasts on Cranswick stock, see the GB:CWK Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 18, 2025